Table 6 Biometric, lipoprotein profile distributions, assessment- insulin resistance and blood glucose distributions in relation to the PPARγ C161→T genotypes in CAD with T2DM patients

Age

62.64 ± 11.22

63.00 ± 12.87

66.00 ± 11.33

63.49 ± 12.61

Weight (kg)

64.35 ± 11.09 *

60.82 ± 9.16*

61.21 ± 7.31

61.38 ± 9.24

Height (m)

1.64 ± 0.09

1.63 ± 0.07

1.64 ± 0.07

1.63 ± 0.07

BMI (kg/m²)

23.94 ± 5.50

22.57 ± 3.62

24.06 ± 3.22

22.82 ± 3.58

TC (mmol/L)

4.66 ± 1.09

4.54 ± 1.17

4.19 ± 0.68

4.48 ± 1.11

Trig (mmol/L)

2.52 ± 1.59 *

1.68 ± 0.96 *

1.64 ± 0.46

1.67 ± 0.89*

HDL (mmol/L)

1.21 ± 0.38

1.22 ± 0.43

1.22 ± 0.24

1.22 ± 0.41

LDL (mmol/L)

2.74 ± 0.73

2.73 ± 0.91

2.38 ± 0.86

2.68 ± 0.90

apoA1 (g/L)

1.27 ± 0.19

1.25 ± 0.24

1.26 ± 0.10

1.25 ± 0.22

apoB (g/L)

1.02 ± 0.22*

0.94 ± 0.24*

0.94 ± 0.19

0.94 ± 0.23*

Lp(a) (mg/L) ^Δ

1.82 ± 0.52

1.82 ± 0.53

1.32 ± 0.22

1.75 ± 0.53

FBS (mmol/L)

6.80 ± 2.26

7.32 ± 2.81

7.24 ± 2.49

7.23 ± 2.74

PPBS (mmol/L)

9.58 ± 3.90

10.73 ± 4.83

10.37 ± 4.36

10.67 ± 4.73

RI ^Δ

1.42 ± 0.38

1.48 ± 0.42

1.34 ± 0.37

1.45 ± 0.41